搜索
COSCIENS Biopharma Inc
CSCI添加自选
2.720USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
8.64M总市值
亏损市盈率 TTM
关于 COSCIENS Biopharma Inc 公司
COSCIENS Biopharma Inc.（前身为 Aeterna Zentaris Inc.）是一家专业生物制药公司，致力于开发和商业化各种药品和诊断产品组合，包括专注于未满足医疗需求领域的产品。其主要产品 macimorelin（Macrilen；Ghryvelin）是一种口服测试，用于诊断成人生长激素缺乏症 (AGHD)。该公司还致力于开发治疗资产和专有提取技术，该技术用于生产可再生植物资源中的活性成分，用于药妆产品（即燕麦β-葡聚糖和燕麦生物碱，它们存在于 Aveeno 和 Burt's Bees 等护肤品品牌配方中），并正在开发为潜在的营养保健品和/或药品。
COSCIENS Biopharma Inc简介
公司代码CSCI
公司名称COSCIENS Biopharma Inc
上市日期Dec 19, 1995
CEOMs. Anna Biehn
员工数量- -
证券类型Ordinary Share
年结日Dec 19
公司地址C/O Norton Rose Fulbright Canada Llp
城市TORONTO
上市交易所The Toronto Stock Exchange
国家Canada
邮编M5K 1E7
电话18439003201
网址https://www.cosciensbio.com/
公司代码CSCI
上市日期Dec 19, 1995
CEOMs. Anna Biehn
COSCIENS Biopharma Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Mr. Robert A. Seager
Mr. Robert A. Seager
Director
Director
--
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Michel Regnier
Mr. Michel Regnier
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
Mr. Ronald W. (Ronnie) Miller
Mr. Ronald W. (Ronnie) Miller
Director
Director
--
--
Mr. Peter H. Puccetti
Mr. Peter H. Puccetti
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David Spear
Mr. David Spear
Director
Director
--
--
Mr. Anthony J. Giovinazzo
Mr. Anthony J. Giovinazzo
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Mr. Robert A. Seager
Mr. Robert A. Seager
Director
Director
--
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Michel Regnier
Mr. Michel Regnier
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
常见问题
COSCIENS Biopharma Inc的前五大股东是谁？
COSCIENS Biopharma Inc 的前五大股东如下：Dr. Ulrich Kosciessa
有多少机构持有COSCIENS Biopharma Inc(CSCI)的股份？
截至2026Q1，共有31家机构持有COSCIENS Biopharma Inc的股份，合计持有的股份价值约为257.26K，占公司总股份的8.08%。与2025Q4相比，机构持股有所增加，增幅为-38426.00。